Our findings confirm the predictive value of the previously published CD8 radiomics score in patients with solid tumors treated with IORT combinations.13 Moreover, the results suggest that global spatial reasoning on this signature through a statistical analysis of the distribution of this score across patient’s lesions could be a promising method to assess tumor heterogeneity and to predict clinical outcomes. This evidence concerns the gene CD8A and neoplasm.